NIR Diagnostics Exercises Rights Under Tax Assisted Financing

NIR Diagnostics, a developer of near-infrared handheld reagentless medical instruments, announced that, further to the tax assisted financing announced on Dec. 31, 2004, the company has exercised its rights to reacquire 100 percent interest in the GlucoNIR business.

Canada NewsWire (http://www.newswire.ca/en/releases/archive/February2005/14/c4113.html)